<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />



<meta name="date" content="2026-02-13" />

<title>KOPRAN</title>

<script src="rmdlib/header-attrs-2.30/header-attrs.js"></script>
<script src="rmdlib/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="rmdlib/bootstrap-3.3.5/css/flatly.min.css" rel="stylesheet" />
<script src="rmdlib/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="rmdlib/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="rmdlib/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="rmdlib/navigation-1.1/tabsets.js"></script>
<script src="rmdlib/accessible-code-block-0.0.1/empty-anchor.js"></script>
<link href="rmdlib/font-awesome-6.4.0/css/all.min.css" rel="stylesheet" />
<link href="rmdlib/font-awesome-6.4.0/css/v4-shims.min.css" rel="stylesheet" />
<meta name="description" content="Indian equities analysis, margin reports, risk, etc..." />
<meta property="og:image" content="https://avatars3.githubusercontent.com/u/21966469?s=400&v=4" />

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>










<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->




</head>

<body>


<div class="container-fluid main-container">




<div class="navbar navbar-inverse  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">StockViz</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-globe"></span>
     
    Macro
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-bnd.html">Fixed Income</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-cur.html">Currencies</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-cmdy.html">Commodities</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-arrows-v"></span>
     
    52w H&amp;L
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/52wk-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/52wk-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-rocket"></span>
     
    ATH
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/ath-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/ath-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-magnet"></span>
     
    Drawdowns
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/drawdowns-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/drawdowns-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-train"></span>
     
    Streaks
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/streaks-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/streaks-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-hand-pointer-o"></span>
     
    Indian Indices
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-risk.html">Performance Metrics</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-IN.html">Index Changes</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-MKT-CAP.html">Classification Changes</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-industry.html">Industry Metrics</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-syn.html">Synthetic Indices</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-vol-NIFTY.html">NIFTY Volatility</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-valuations.html">Valuations</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/results-IN.html">Result Dates</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/eq-in/rp-margin.html">Margin Report</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-shopping-bag"></span>
     
    Funds
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports03/mf/rp-IN.html">Indian Mutual Funds</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports03/pms/rp-IN.html">Indian PMS</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-risk.html">US ETFs</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-sector.html">US Sector ETFs</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-country.html">Country $ ETFs</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-percent"></span>
     
    Fama-French
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-industry.html">Industry</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-factors.html">Factors</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-regression.html">Regressions</a>
    </li>
  </ul>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://stockviz.biz">
    <span class="fa fa-home"></span>
     
  </a>
</li>
<li>
  <a href="https://stockviz.substack.com">
    <span class="fa fa-envelope-o"></span>
     
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore">KOPRAN</h1>
<h3 class="subtitle">Equity Metrics</h3>
<h4 class="date">February 13, 2026</h4>

</div>


<div id="kopran-limited" class="section level1">
<h1>Kopran Limited</h1>
<p><a href="/reports01/index/industry/rp-Pharmaceuticals.html">Pharmaceuticals</a></p>
<div id="annual-returns" class="section level2">
<h2>Annual Returns</h2>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.KOPRAN.fan.png" /></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.KOPRAN.annret.png" /></p>
</div>
<div id="cumulative-returns-and-drawdowns" class="section level2">
<h2>Cumulative Returns and Drawdowns</h2>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.KOPRAN.cumret.png" /></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.KOPRAN.sma.cumret.png" /></p>
<p><br><br></p>
</div>
<div id="fundamentals" class="section level2">
<h2>Fundamentals</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.KOPRAN.eps.png" /></p>
<p><br><br></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.KOPRAN.RevenueFromOperations.png" /></p>
<p><br><br></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.KOPRAN.ebit.png" /></p>
<p><br><br></p>
</div>
<div id="ownership" class="section level2">
<h2>Ownership</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.KOPRAN.ownership.png" /></p>
<p><br><br></p>
</div>
<div id="margined" class="section level2">
<h2>Margined</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.KOPRAN.mtf.png" /></p>
<p><br><br></p>
<p><br />
</p>
</div>
<div id="ai-summary" class="section level2">
<h2>AI Summary</h2>
<p><em>asof: 2025-11-27 </em></p>
<div id="analysis-of-kopran-limited-nsebse-kopran-headwinds-tailwinds-growth-prospects-and-key-risks" class="section level9">
<p class="heading">Analysis of Kopran Limited (NSE/BSE: KOPRAN) – Headwinds, Tailwinds, Growth Prospects, and Key Risks</p>
<p>Kopran Limited is an integrated pharmaceutical company focused on APIs (via subsidiary Kopran Research Laboratories Ltd.) and formulations (oral solids/dry powders). It exports to 50+ countries, with state-of-the-art facilities in Mahad (Maharashtra) and Khopoli (Maharashtra), and a new API/R&amp;D site at Panoli (Gujarat). FY25 full-year revenue was ~Rs. 633 Cr (strong growth from Rs. 360 Cr in FY20), but HY26 (Apr-Sep 2025) showed a slowdown: revenue Rs. 253 Cr (down 14% YoY), EBITDA Rs. 17 Cr (down ~77%), net loss Rs. 2.5 Cr (vs. Rs. 18.5 Cr profit YoY), driven by forex losses (Rs. 58 Cr) and Q2 revenue dip (Rs. 118 Cr). Balance sheet stable (net worth Rs. 501 Cr, debt/equity 0.31x), with strong operating cash flow (Rs. 55 Cr). Recent AGM approved dividend (Rs. 3/share), re-appointments, and auditor.</p>
<div id="headwinds-current-pressures" class="section level12">
<p class="heading"><strong>Headwinds (Current Pressures)</strong></p>
<table>
<colgroup>
<col width="32%" />
<col width="36%" />
<col width="32%" />
</colgroup>
<thead>
<tr class="header">
<th>Factor</th>
<th>Details</th>
<th>Impact</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Revenue Decline &amp; Profitability Squeeze</strong></td>
<td>Q2 FY26 revenue -22% YoY (Rs. 118 Cr); HY26 EBITDA margin 6.75% (vs. 11.6% HY25). API stable but formulations weak.</td>
<td>Weak demand/pricing in exports; one-off forex loss (Rs. 82 Cr in Q2).</td>
</tr>
<tr class="even">
<td><strong>Forex Volatility</strong></td>
<td>Net forex loss Rs. 58 Cr in HY26 (vs. gain Rs. 13 Cr HY25); 50%+ revenue from exports.</td>
<td>Erodes margins; Q2 net loss Rs. 9.9 Cr.</td>
</tr>
<tr class="odd">
<td><strong>High Costs</strong></td>
<td>Finance costs Rs. 4.6 Cr (up YoY); depreciation Rs. 8.5 Cr. Employee/other expenses up.</td>
<td>Debt Rs. 157 Cr; capex (Rs. 32 Cr in HY26) strains cash.</td>
</tr>
<tr class="even">
<td><strong>Inventory/Receivables Build-up</strong></td>
<td>Inventories +2% QoQ (Rs. 174 Cr); receivables Rs. 162 Cr (down from Rs. 215 Cr FY25-end).</td>
<td>Working capital pressure amid slowing sales.</td>
</tr>
</tbody>
</table>
</div>
<div id="tailwinds-supportive-factors" class="section level12">
<p class="heading"><strong>Tailwinds (Supportive Factors)</strong></p>
<table>
<colgroup>
<col width="32%" />
<col width="36%" />
<col width="32%" />
</colgroup>
<thead>
<tr class="header">
<th>Factor</th>
<th>Details</th>
<th>Impact</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Diversified Portfolio &amp; Export Focus</strong></td>
<td>APIs (63% HY26 revenue): Anti-infectives, anti-diabetics, carbapenems; Formulations (37%): Penicillin/non-penicillin, 100% exports (Africa/LatAm/Asia).</td>
<td>Balanced revenue mix; 50% API export/local split resilient.</td>
</tr>
<tr class="even">
<td><strong>Regulatory Strengths</strong></td>
<td>Formulations approved by MHRA-UK, Health Canada, SAHPRA, etc. (15 countries); APIs: USFDA/EU GMP/WHO (non-sterile).</td>
<td>Access to regulated markets; competitive edge.</td>
</tr>
<tr class="odd">
<td><strong>Strong Balance Sheet &amp; Cash Generation</strong></td>
<td>Net worth Rs. 501 Cr (+ve RoNW ~14% historical); OCF Rs. 55 Cr (HY26); debt/equity low (0.31x vs. 0.39x FY20).</td>
<td>Funds capex/growth; dividend payout sustained.</td>
</tr>
<tr class="even">
<td><strong>Historical Momentum</strong></td>
<td>Revenue CAGR ~12% FY20-25 (Rs. 360 Cr to 633 Cr); net profit CAGR ~15%.</td>
<td>Proven execution in pharma value chain.</td>
</tr>
</tbody>
</table>
</div>
<div id="growth-prospects" class="section level12">
<p class="heading"><strong>Growth Prospects</strong></p>
<ul>
<li><strong>Short-Term (1-2 Yrs)</strong>: Revenue recovery via inventory drawdown, forex hedging, and Q3/H1 ramp-up. Target EBITDA margin 11-12% (historical avg.). Dividend yield ~1.5% attractive.</li>
<li><strong>Medium-Term (2-5 Yrs)</strong>: | Driver | Opportunity | |——–|————-| | <strong>R&amp;D &amp; Capacity</strong> | Niche APIs/intermediates; Panoli facility; process yields up 5-10%. | | <strong>Market Expansion</strong> | New geographies/customers; regulated filings; reduce China dependency (self-sufficiency in intermediates). | | <strong>Synergies</strong> | API-to-formulations integration; automation in packing. | | <strong>Projections</strong> | Sales &gt;Rs. 750 Cr FY26 (analyst est.); EPS Rs. 8-10 (FY26). |</li>
<li><strong>Long-Term</strong>: Global pharma tailwinds (anti-infectives/diabetes demand); 20%+ CAGR potential via exports (current 90%+ formulations).</li>
</ul>
</div>
<div id="key-risks" class="section level12">
<p class="heading"><strong>Key Risks</strong></p>
<table>
<colgroup>
<col width="16%" />
<col width="51%" />
<col width="32%" />
</colgroup>
<thead>
<tr class="header">
<th>Risk</th>
<th>Probability/Impact</th>
<th>Mitigation</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Forex &amp; Commodity Volatility</strong></td>
<td>High/High</td>
<td>Hedging; rupee stability assumed.</td>
</tr>
<tr class="even">
<td><strong>Regulatory/Compliance</strong></td>
<td>Medium/High</td>
<td>Strong track record; sterile facility pending full USFDA.</td>
</tr>
<tr class="odd">
<td><strong>Debt &amp; Capex Overrun</strong></td>
<td>Medium/Medium</td>
<td>Low leverage; OCF covers interest 3.7x.</td>
</tr>
<tr class="even">
<td><strong>Competition/Geopolitics</strong></td>
<td>Medium/Medium</td>
<td>Diversified exports; China+1 shift favors India.</td>
</tr>
<tr class="odd">
<td><strong>Execution (Capex Delay)</strong></td>
<td>Medium/High</td>
<td>Rs. 353 Cr non-current assets; Panoli ramp-up critical.</td>
</tr>
<tr class="even">
<td><strong>Demand Slowdown</strong></td>
<td>Low/Medium</td>
<td>Pharma resilient; monitor LatAm/Africa exposure.</td>
</tr>
</tbody>
</table>
<p><strong>Overall Outlook</strong>: <strong>Neutral to Positive</strong>. Near-term headwinds (forex, Q2 softness) pressure profitability, but robust fundamentals (exports, regulations, cash flow) support recovery. Growth hinges on forex stabilization and capex execution. Target price upside 20-30% if FY26 sales hit Rs. 700+ Cr (current mcap ~Rs. 1,200 Cr at Rs. 250/share). Investors: Hold/Buy on dips for 12-15% RoE potential. Monitor Q3 results for forex trend.</p>
<p><em>Data as of Nov 12, 2025 filings; not investment advice.</em></p>
</div>
</div>
</div>
</div>

&nbsp;
&nbsp;
<hr />
<p style="text-align: center;">Copyright &copy; 2023 SAS Data Analytics Pvt. Ltd. All rights reserved.</p>
<p style="text-align: center;"><a href="https://github.com/stockviz/reports/issues">&#x1F41E;</a></p>



</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
